A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer

Author:

Taylor I1,Machin D2,Mullee M2,Trotter G1,Cooke T1,West C3

Affiliation:

1. University Surgical Unit, Liverpool, UK

2. Department of Community, Medicine and Medical Statistics, University of Southampton, Liverpool, UK

3. Biostatistics Unit, University of Liverpool, Liverpool, UK

Abstract

Abstract In this randomized trial adjuvant cytotoxic portal vein perfusion in patients undergoing surgery for colorectal cancer without liver metastases was assessed to determine whether the incidence of meta-chronous liver metastases could be reduced and survival thereby improved. There were 127 control patients and 117 patients who received adjuvant perfusion. A further 13 patients were excluded following randomization because of cirrhosis in 1, liver metastases at laparotomy in 3 and technical problems with cannulation in 9. Dukes' staging and degree of differentiation were similar in the two groups. There were fewer liver metastases in the perfusion patients and overall survival was improved. However, the benefit appears to be greatest in patients with Dukes' B colon cancer.

Publisher

Oxford University Press (OUP)

Subject

Surgery

Reference19 articles.

1. The cytological demonstration and significance of tumour cells in the mesenteric blood in patients with colorectal cancer;Fisher;Surg Gynecol Obstet,1955

2. Experimental studies of factors influencing hepatic metastases. III. Effect of surgical trauma with special reference to liver injury;Fisher;Ann Surg,1959

3. Carcinoma of the colon and rectum: circulatory malignant cells and 5 year survival;Griffiths;Cancer,1973

4. Prophylactic treatment of cancer;Cruz;Surgery,1956

5. Cancer of the colon. Five to 40 year survival rates following resection utilizing the isolation technique;Turnbull;Ann R Coll Surg,1970

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3